… R Baker and J Streatfield … R Baker and J Streatfield … Chambers R, Belcher J. Work
patterns ofgeneral practitioners before and after the introduction of the 1990 contract. Br …

The use of plants for medicinal purposes dates back thousands of years but genetic engineering
of plants to produce desired biopharmaceuticals is much more recent. As the demand …

Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from
soluble recombinant antigens by stronger protective immunogenicity associated with the VLP …

Plant cells are ideal bioreactors for the production and oral delivery of vaccines and
biopharmaceuticals, eliminating the need for expensive fermentation, purification, cold storage, …

Plants offer an alternative to microbial fermentation and animal cell cultures for the production
of recombinant proteins. For protein pharmaceuticals, plant systems are inherently safer …

Numerous studies have shown that viral epitopes and subunits of bacterial toxins can be
expressed and correctly processed in transgenic plants. The recombinant proteins induce …

In the last few years, plants have become an increasingly attractive platform for recombinant
protein production. This builds on two decades of research, starting with transgenic …

The Arabidopsis chlorophyll a/b binding protein (CAB) gene underexpressed 1 (cue1) mutant
underexpresses light-regulated nuclear genes encoding chloroplast-localized proteins. …

Plant systems are reviewed with regard to their ability to express and produce subunit
vaccines. Examples of different types of expression systems producing a variety of vaccine …

Recombinant plant expression systems offer a means to produce large quantities of selected
antigens for subunit vaccines. Cereals are particularly well-suited expression vehicles …